The syntactic and nonsyntactic strategies used for understanding sentences by Spanish-speaking Broca's aphasic patients in off-line tasks were analysed. It is emphasized that given the characteristics of syntax in Spanish, such as its flexibility (greater freedom in the order of constituents), the function of the direct object with the preposition a (to) and the effect of determiners, research with Spanish-speaking patients will allow for a characterization of specific disorders that cannot be generalized on the basis of research conducted in other languages. A linguistic instrument was applied to 10 Broca's aphasic patients. A forced choice task was used in which the patient listened to 190 different reversible sentences and was asked to select one of four options presented on a plate; each option contained a pair of animals performing a specific act and only one option was correct. The results showed significant differences in the use of syntactic and nonsyntactic strategies. Broca's aphasic patients used only morpho-syntactic marks with high cue validity. No significant effects of word order were found. These findings imply the existence of specific off-line linguistic mechanisms that influence the comprehension in non-fluent aphasic patients.
The purpose of this study was to examine the performance of the Functional Activities Questionnaire (FAQ) in four American ethnic groups (N = 691), evaluate the influence of demographic factors and depressive symptoms on the FAQ and compare its performance with two cognitive screening measures, the Mini-Cog and the MMSE. Half of FAQ items were less frequently done by men than women. FAQ total scores did not differ across the four ethnic groups but regression analyses indicated effects for age, education and depressive symptoms. The Mini-Cog and MMSE evidenced demographic and depressive symptom effects. FAQ performed well across the ethnic groups. Development of age and education corrections for the FAQ is recommended as is a screen for depression in cognitive screening batteries.
Background: Plasma NfL (pNfL) levels are elevated in many neurological disorders. However, the utility of pNfL in a clinical setting has not been established. Objective: In a cohort of diverse older participants, we examined: 1) the association of pNfL to age, sex, Hispanic ethnicity, diagnosis, and structural and amyloid imaging biomarkers; and 2) its association to baseline and longitudinal cognitive and functional performance. Methods: 309 subjects were classified at baseline as cognitively normal (CN) or with cognitive impairment. Most subjects had structural MRI and amyloid PET scans. The most frequent etiological diagnosis was Alzheimer’s disease (AD), but other neurological and neuropsychiatric disorders were also represented. We assessed the relationship of pNfL to cognitive and functional status, primary etiology, imaging biomarkers, and to cognitive and functional decline. Results: pNfL increased with age, degree of hippocampal atrophy, and amyloid load, and was higher in females among CN subjects, but was not associated with Hispanic ethnicity. Compared to CN subjects, pNfL was elevated among those with AD or FTLD, but not those with neuropsychiatric or other disorders. Hippocampal atrophy, amyloid positivity and higher pNfL levels each added unique variance in predicting greater functional impairment on the CDR-SB at baseline. Higher baseline pNfL levels also predicted greater cognitive and functional decline after accounting for hippocampal atrophy and memory scores at baseline. Conclusion: pNfL may have a complementary and supportive role to brain imaging and cognitive testing in a memory disorder evaluation, although its diagnostic sensitivity and specificity as a stand-alone measure is modest. In the absence of expensive neuroimaging tests, pNfL could be used for differentiating neurodegenerative disease from neuropsychiatric disorders.
Semantic intrusion (SI) errors may highlight specific breakdowns in memory associated with preclinical Alzheimer disease (AD); however, there have been no investigations to determine whether SI errors occur with greater frequency in persons with amnestic mild cognitive impairment (aMCI) confirmed as amyloid positive (Amy+) vs those who have clinical symptoms of aMCI-AD with negative amyloid scans (suspected non-AD pathology [SNAP]) or persons who are diagnosed with other brain disorders affecting cognition.
Methods
Eighty-eight participants with aMCI underwent brain amyloid PET and MRI scans and were classified as early AD (Amy+), SNAP (Amy−), or other neurological/psychiatric diagnosis (Amy−). We focused on SI on the Loewenstein-Acevedo Scales for Semantic Interference and Learning (LASSI-L) targeting proactive semantic interference (PSI; old semantic learning interferes with new semantic learning), failure to recover from PSI after an additional learning trial (frPSI), and retroactive semantic interference (new semantic learning interferes with memory for old semantic learning).
Results
SIs on measures of PSI and frPSI distinguished between Amy+ AD and SNAP and other non-AD cases. PSI and frPSI intrusions evidenced moderately high associations with reduced volumes in the entorhinal cortex, superior temporal regions, and supramarginal gyrus. No such associations were observed in cases with SNAP.
Conclusions
SIs on the LASSI-L related to PSI and frPSI uniquely differentiated Amy+ and Amy− participants with aMCI and likely reflect deficits with inhibition and source memory in preclinical AD not captured by traditional cognitive measures. This may represent a specific, noninvasive test successful at distinguishing cases with true AD from those with SNAP.
